We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.2B
AUM Growth
+$243M
Cap. Flow
-$34.7M
Cap. Flow %
-0.67%
Top 10 Hldgs %
25.03%
Holding
755
New
88
Increased
274
Reduced
213
Closed
63

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$45.4M
2
MKTX icon
MarketAxess Holdings
MKTX
+$25.6M
3
BLK icon
Blackrock
BLK
+$25.5M
4
ADBE icon
Adobe
ADBE
+$24.1M
5
MSFT icon
Microsoft
MSFT
+$18.9M

Sector Composition

Rank Sector Weight
1 Healthcare 18.85%
2 Technology 16.27%
3 Financials 15.32%
4 Consumer Discretionary 14.37%
5 Industrials 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YUM icon
151
Yum! Brands
YUM
$41.1B
$2.82M 0.05%
53,740
+20,277
+61% +$1.06M
LULU icon
152
lululemon athletica
LULU
$13.1B
$2.82M 0.05%
53,673
-21,612
-29% -$1.09M
RTX icon
153
RTX Corp
RTX
$286B
$2.8M 0.05%
46,351
-12,706
-22% -$769K
NJ
154
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
$2.8M 0.05%
153,335
+21,812
+17% +$408K
GRFS
155
Grifois
GRFS
$5.32B
$2.79M 0.05%
172,052
-3,030
-2% -$51.2K
NVS icon
156
Novartis
NVS
$294B
$2.71M 0.05%
35,199
+673
+2% +$53.5K
CSTE icon
157
Caesarstone
CSTE
$111M
$2.65M 0.05%
61,214
-9,855
-14% -$376K
CNI icon
158
Canadian National Railway
CNI
$76.5B
$2.59M 0.05%
46,405
-18,315
-28% -$1.07M
ALXN
159
DELISTED
Alexion Pharmaceuticals
ALXN
$2.59M 0.05%
13,586
-105
-0.8% -$18.3K
SPSC icon
160
SPS Commerce
SPSC
$3.03B
$2.58M 0.05%
73,420
-7,416
-9% -$271K
EMC
161
DELISTED
EMC CORPORATION
EMC
$2.55M 0.05%
99,130
+32,871
+50% +$853K
VGK icon
162
Vanguard FTSE Europe ETF
VGK
$31B
$2.54M 0.05%
50,996
+14,045
+38% +$718K
KMB icon
163
Kimberly-Clark
KMB
$36.6B
$2.54M 0.05%
19,949
+519
+3% +$62.3K
VZ icon
164
Verizon
VZ
$205B
$2.54M 0.05%
54,886
+2,000
+4% +$90.8K
MRSH
165
Marsh
MRSH
$90.7B
$2.5M 0.05%
45,069
-1,520
-3% -$83.8K
PCP
166
DELISTED
PRECISION CASTPARTS CORP
PCP
$2.49M 0.05%
10,749
-1,105
-9% -$255K
AER icon
167
AerCap
AER
$23.3B
$2.48M 0.05%
57,348
-43,212
-43% -$1.81M
MJN
168
DELISTED
Mead Johnson Nutrition Company
MJN
$2.47M 0.05%
31,330
-6,541
-17% -$515K
EEM icon
169
iShares MSCI Emerging Markets ETF
EEM
$31.4B
$2.45M 0.05%
76,198
-2,278
-3% -$78.1K
VB icon
170
Vanguard Morningstar Small-Cap ETF
VB
$82.2B
$2.45M 0.05%
22,160
+4,391
+25% +$498K
IVV icon
171
iShares Core S&P 500 ETF
IVV
$900B
$2.44M 0.05%
11,928
+1,521
+15% +$314K
GIS icon
172
General Mills
GIS
$21.6B
$2.42M 0.05%
41,948
-160
-0.4% -$9.21K
BABA icon
173
Alibaba
BABA
$289B
$2.4M 0.05%
29,521
-522
-2% -$41K
BMRN icon
174
BioMarin Pharmaceuticals
BMRN
$12.6B
$2.38M 0.05%
22,752
-105
-0.5% -$11K
BWLD
175
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$2.35M 0.05%
14,727
-3,543
-19% -$591K

Similar funds

Geneva Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, Geneva Advisors held 755 positions worth $5.2B, up 4.9% from $4.96B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q4 2015 filing shows 88 new, 274 increased, 213 reduced and 63 closed positions. Its largest new stake was Adobe: 268,155 shares worth $25.2M. The largest sale was Ameriprise Financial, an estimated $48.8M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Geneva Advisors's largest Q4 2015 buy was Adobe: 268,155 shares worth $25.2M.
  • Geneva Advisors added most to Alphabet (Google) Class A in Q4 2015, an estimated $45.4M increase.
  • Geneva Advisors's biggest Q4 2015 reduction was Ameriprise Financial, cutting an estimated $48.8M.
  • Geneva Advisors fully exited HCA Healthcare in Q4 2015, selling an estimated $20.8M.
  • Geneva Advisors's ten largest holdings make up 25% of its $5.2B portfolio in Q4 2015.
  • Geneva Advisors opened 88 new positions and closed 63 in Q4 2015.
  • Geneva Advisors's portfolio value rose 4.9% quarter-over-quarter to $5.2B.

Based on Geneva Advisors's 13F filing for Q4 2015, filed 4 Feb 2016.